SCHEMBL6525462

SCHEMBL6525462

CCCc1ccc(CN2CC(Oc3ccc(-c4ccc(C(N)=O)c(F)c4)nc3)C2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
RAB9A P51151 2/20 0.43
PKM P14618 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GPR119 Q8TDV5 3/20 0.41
PARP1 P09874 1/20 0.40
GRM2 Q14416 2/20 0.39
THRB P10828 2/20 0.38
MLNR O43193 3/20 0.38
CYP3A4 P08684 1/20 0.38
S1PR1 P21453 2/20 0.38
KCNH2 Q12809 1/20 0.38
MCHR1 Q99705 1/20 0.38
MAPT P10636 2/20 0.37
S1PR4 O95977 1/20 0.37
S1PR3 Q99500 1/20 0.37
S1PR5 Q9H228 1/20 0.37
PARP15 Q460N3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6519362 0.93 GPR119 (0.45) TP53GPR119PARP1GRM2MLNR
SCHEMBL6521815 0.89 GPR119 (0.40) GPR119PARP1GRM2MLNRCYP3A4
SCHEMBL6523552 0.89 GRM2 (0.40) GPR119PARP1GRM2MLNRCYP3A4
SCHEMBL6521804 0.88 CHRM2 (0.44) GPR119GRM2KCNH2
SCHEMBL3662088 0.88 STAT3 (0.41) GPR119PARP1S1PR1S1PR5
SCHEMBL12788257 0.87 GPR119 (0.42) GPR119PARP1GRM2MLNRCYP3A4
SCHEMBL2895333 0.82 GPR119 (0.35) GPR119GRM2S1PR1S1PR4S1PR5
SCHEMBL3801414 0.81 CHRM2 (0.41) GPR119PARP1MCHR1
SCHEMBL2896254 0.81 GPR119 (0.39) GPR119PARP1GRM2PARP15PARP10
SCHEMBL3658326 0.81 LIPG (0.45) S1PR1S1PR5HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2011-03-10 US disclosed
WO-2009050522-A1 AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS PROSIDION LIMITED (GB) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059942-A1 Azetidinyl G-Protein Coupled Receptor Agonists GPR119, GIPR, GPR39 SMN1; SMN2 3181/4885NPC1 1153/4885TP53 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.